Emcure Pharmaceuticals IPO Hits Remarkable 67.87x Subscription on Day 3!

Emcure Pharmaceuticals' IPO Day 3: QIBs lead with 195.83x, Non-Institutional at 48.32x, RIIs at 7.21x, and Employees at 8.81x, totaling a robust 67.87x subscription, indicating strong market interest.
Emcure Pharmaceuticals IPO Hits Remarkable 67.87x Subscription on Day 3!

Emcure Pharmaceuticals IPO on Day 3 shows varied interest across groups: QIBs subscribed 195.83 times, Non-Institutional Investors at 48.32 times, Retail Individual Investors 7.21 times, and Employees 8.81 times, leading to a total subscription of 67.87 times, showing robust market enthusiasm.

Investor CategorySubscription (times)Shares OfferedShares Bid For
QIB Investors195.8337,62,89673,68,91,932
HNIs / NIIs48.3229,49,52314,25,26,748
Retail Investors7.2168,82,2194,96,18,982
Employees8.81      1,08,9009,59,728

Source: NSE

How To Check Emcure Pharmaceuticals Limited IPO Subscription Status?

Steps to check the IPO subscription status on NSE

Following are the steps to check it through the NSE website

  • Visit NSE‘s official website.
  • Navigate to the ‘Market Data’ tab.
  • Choose ‘IPO’.
  • Select the Emcure Pharmaceuticals Limited IPO to check its subscription status.
  • Opt for either NSE Bid details or Consolidated Bid details.
  • Explore the total number of bids received from various investors. 

Emcure Pharmaceuticals IPO Allotment Status

The allotment date for the Emcure Pharmaceuticals IPO is set for July 8, 2024, with shares priced at a range of ₹960 to ₹1008  per share and a face value of ₹ 10. The offering consists of lots of 14 shares, with bids accepted for these lots or their multiples. 

Emcure Pharmaceuticals IPO Subscription Status

Emcure Pharmaceuticals IPO saw varied interest on Day 2, with subscriptions reaching 1.00 times for Qualified Institutional Buyers, 13.67 times for Non-Institutional Investors, 3.43 times for Retail Individual Investors, and 4.83 times for Employees, totaling a subscription rate of 4.98 times.

Emcure Pharmaceuticals Limited IPO Listing Date 

Emcure Pharmaceuticals IPO is expected to be listed on the NSE SME on July 10, 2024.

Read More News




Trade Intraday and Futures & Options